AstraZeneca Strikes 'Most Favored Nation' Price Deal

Pharmaceutical giant AstraZeneca on Friday cut a deal with the Trump administration to reduce drug prices in the United States, agreeing to provide its medications for Medicaid beneficiaries at discount prices....

Already a subscriber? Click here to view full article